An examination of psychotropic medication side effects: Does taking a greater number of psychotropic medications from different classes affect presentation of side effects in adults with ID?

Research in Developmental Disabilities

Volumn 31, Issue 6, 2010, Pages 1561-1569

  Mahan, Sara ^a   Holloway, Jodie ^b   Bamburg, Jay W ^b   Hess, Julie A ^a   Fodstad, Jill C ^a   Matson, Johnny L ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b Pinecrest Supports and Services Center   (United States)

Author keywords

ID; MEDS; Polypharmacy; Psychotropic medication; Side effects

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BUSPIRONE; CARBAMAZEPINE; CHLORPROMAZINE; CLONAZEPAM; CLONIDINE; DEPAKOTE ER; FLUVOXAMINE MALEATE; HALOPERIDOL; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SERTRALINE; THIORIDAZINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ABNORMAL BEHAVIOR; ABNORMAL FECES; ADULT; ADVERSE OUTCOME; AGED; AGGRESSION; AGITATION; AKATHISIA; AKINESIA; ANXIETY; APPETITE DISORDER; ARTICLE; ATAXIA; AUTOMUTILATION; BALANCE DISORDER; BEHAVIOR DISORDER; BLURRED VISION; BODY POSTURE; BODY WEIGHT DISORDER; BRADYKINESIA; BREAST DISEASE; CLINICAL ASSESSMENT TOOL; COARSE FACE; COLD TOLERANCE; COMA; CONFUSION; CONSTIPATION; CONTROLLED STUDY; DENTAL CARIES; DEPRESSION; DIARRHEA; DISORIENTATION; DIZZINESS; DROWSINESS; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRY THROAT; DYSKINESIA; DYSPNEA; EDEMA; ENURESIS; EPISTAXIS; EYE MOVEMENT DISORDER; EYELID REFLEX; FACIAL EXPRESSION; FATIGUE; FEMALE; GAIT DISORDER; GINGIVA BLEEDING; GINGIVA HYPERPLASIA; HAIR DISEASE; HAIR LOSS; HEART ARRHYTHMIA; HEARTBURN; HICCUP; HUMAN; HYPERSALIVATION; HYPERTENSION; HYPOTENSION; INTELLECTUAL IMPAIRMENT; LACTATION DISORDER; LEARNING DISORDER; LETHARGY; LEUKOCYTE COUNT; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MATSON EVALUATION OF DRUG SIDE EFFECTS; MEMORY DISORDER; MENSTRUAL IRREGULARITY; MOTOR DYSFUNCTION; MOUTH DISEASE; MUSCLE RIGIDITY; NAUSEA AND VOMITING; NERVOUSNESS; NYSTAGMUS; OPISTHOTONUS; PARKINSONISM; PHOTOPHOBIA; PHOTOSENSITIVITY; PRESCRIPTION; RESPIRATORY TRACT ALLERGY; RESTLESSNESS; SCORING SYSTEM; SEBORRHEA; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SINUS CONGESTION; SKIN BRUISING; SKIN DISCOLORATION; SLEEP DISORDER; SLURRED SPEECH; SORE THROAT; STEREOTYPY; SWEAT GLAND DISEASE; SYNCOPE; TACHYPNEA; THORAX PAIN; TIC; TONGUE DISEASE; TOOTH PAIN; TREMOR; URINE RETENTION; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; POLYPHARMACY; PSYCHOTROPIC DRUGS; YOUNG ADULT;

EID: 77957170616     PISSN: 08914222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ridd.2010.05.006     Document Type: Article

References (65)

1. Advokat C.D., Mayville E.A., Matson J.L. Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with mental retardation. Research in Developmental Disabilities 2000, 21:75-84.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, Author, Washington, DC. 4th ed.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders-text revision 2000, Author, Washington, DC. 4th ed.
4. Applegate H., Matson J.L., Cherry K.E. An evaluation of functional variables affecting severe problem behaviors in adults with mental retardation by using the Questions About Behavioral Function scale (QABF). Research in Developmental Disabilities 1999, 20:229-237.
5. Ayllon T., Azrin N. The token economy: A motivational system for therapy and rehabilitation 1968, Appleton Century Crofts, New York.
6. Borthwick-Duffy S.A. Epidemiology and prevalence of psychopathology in people with mental retardation. Journal of Consulting and Clinical Psychology 1994, 62:17-27.
7. Carr J.E., Severtson J.M., Lepper T.L. Noncontingent reinforcement in an empirically supported treatment for problem behavior exhibited by individuals with developmental disabilities. Research in Developmental Disabilities 2009, 30:44-57.
8. Coe D.A., Matson J.L., Russell D.W., Slifer K.J., Capone G.T., Baglio C., et al. Behavior problems of children with Down syndrome and life events. Journal of Autism and Developmental Disorders 1999, 29:149-156.
9. Dawson J.E., Matson J.L., Cherry K.E. An analysis of maladaptive behaviors in persons with autism, PDD-NOS, and mental retardation. Research in Developmental Disabilities 1998, 19:439-448.
10. De Leon J., Greenlee B., Barber J., Sabaawi M., Singh N.N. Practical guidelines for the use of new generation antipsychotics drugs (except clozapine) in adult individuals with intellectual disabilities. Research in Developmental Disabilities 2009, 30:613-669.
11. Duncan D., Matson J.L., Bamburg J.W., Cherry K.E., Buckley T. The relationship of self-injurious behavior and aggression to social skills in persons with severe and profound learning disability. Research in Developmental Disabilities 1999, 20:441-448.
12. Embregts P.J.C.M., Didden R., Schreuder N., Huitnik C., van Nieuwenhuijzen M. Aggressive behavior in individuals with moderate to borderline intellectual disabilities who live in a residential facility: An evaluation of functional variables. Research in Developmental Disabilities 2009, 30:682-688.
13. Erdfelder E., Faul F., Buchner A. GPOWER: A general power analysis program. Behavior Research Methods, Instruments & Computers 1996, 28:1-11.
14. Fabio R.A., Giannatiempo S., Antonietti A., Budden S. The role of stereotypies in overselectivity process in Rett syndrome. Research in Developmental Disabilities 2009, 30:136-145.
15. Field A. Discovering statistics using SPSS 2005, Sage, London. 2nd ed.
16. Fleming I., Caine A., Ahmed S., Smith S. Aspects of the use of psychoactive medication among people with developmental disabilities who have been resettled from long-stay hospitals into dispersed housing. Journal of Applied Research in Intellectual Disabilities 1996, 9:194-205.
17. Gal E., Dyck M.J., Passmore A. The relationship between stereotyped movements and self-injurious behavior in children with developmental or sensory disabilities. Research in Developmental Disabilities 2009, 30:342-352.
18. Ganzini L., Casey D.E., Hoffman W.F., McCall A.L. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Archives of Internal Medicine 1993, 153:1469-1475.
19. Ghaziuddin M. Autism in mental retardation. Current Opinion in Psychiatry 2000, 13:481-484.
20. Hammock R.G., Schroeder S.R., Levine W.R. The effect of clozapine on self-injurious behavior. Journal of Autism and Developmental Disorders 1995, 25:611-626.
21. Hellings J.A., Zarcone J.R., Reese M., Valdovinos M.G., Marquis J.G., Fleming K.K., et al. A crossover study of risperidone in children, adolescents, and adults with mental retardation. Journal of Autism and Developmental Disorders 2006, 36:401-411.
22. Holden B., Gitlesen J.P. The overlap between psychiatric symptoms and challenging behaviour: A preliminary report. Research in Developmental Disabilities 2009, 30:210-218.
23. Kuhn D.E., Matson J.L. A validity study of the Screening Tool of Feeding Problems (STEP). Journal of Intellectual and Developmental Disability 2002, 27:161-167.
24. Kuhn D.E., Matson J.L. Assessment of feeding and mealtime behavior problems in persons with mental retardation. Behavior Modification 2004, 28:638-648.
25. Lancioni G.E., Singh N.N., O'Reilly M.F., Sigafoos J. An overview of behavioral strategies for reducing hand-related stereotypies of persons with severe to profound intellectual and multiple disabilities: 1995-2007. Research in Developmental Disabilities 2009, 30:20-43.
26. Lang R., White P.J., Machalicek W., Rispoli M., Kang S., Aguilar J., et al. Treatment of bruxism in individuals with developmental disabilities: A systematic review. Research in Developmental Disabilities 2009, 30:809-818.
27. Laud R.B., Matson J.L. The relationship between manic symptoms on the DASH II and YMRS and feeding/mealtime behavior problems. Research in Developmental Disabilities 2006, 27:559-566.
28. Lott R.S., Kerrick J.M., Cohen S.A. Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance. Psychopharmacology Bulletin 1996, 32:721-729.
29. Maas A.P.H.M., Didden R., Bouts L., Smits M.G., Curfs L.M.G. Scatter plot analysis of excessive daytime sleepiness and severe disruptive behavior in adults with Prader-Willi syndrome: A pilot study. Research in Developmental Disabilities 2009, 30:529-537.
30. Matson J.L., Anderson S.J., Bamburg J.W. The relationship of social skills to psychopathology for individuals with mild and moderate mental retardation. British Journal of Developmental Disabilities 2000, 46:15-22.
31. Matson J.L., Baglio C.S. Administrator's manual: Matson Evaluation of Drug Side Effects 1998, Disability Consultants, LLC, Baton Rouge, LA.
32. Matson J.L., Bamburg J.W. Reliability of the Assessment of Dual Diagnosis (ADD). Research in Developmental Disabilities 1998, 19:89-95.
33. Matson J.L., Bamburg J.W. A descriptive study of pica behavior in persons with mental retardation. Journal of Developmental and Physical Disabilities 1999, 11:353-361.
34. Matson J.L., Bamburg J.W., Mayville E.A., Logan J.R. Tardive dyskinesia and developmental disabilities: An examination of demographics and topography in persons with dual diagnosis. British Journal of Developmental Disabilities 2000, 46:119-130.
35. Matson J.L., Bamburg J.W., Mayville E.A., Pinkston J., Bielecki J., Kuhn D., et al. Psychopharmacology and mental retardation: A 10 year review (1990-1999). Research in Developmental Disabilities 2000, 21:263-296.
36. Matson J.L., Boisjoli J.A. Multiple versus single maintaining factors of challenging behaviors as assessed by the QABF for adults with intellectual disabilities. Journal of Intellectual and Developmental Disability 2007, 32:39-44.
37. Matson J.L., Dixon D.R., Matson M.L. Assessing and treating aggression in children and adolescents with developmental disabilities: A 20-year review. Educational Psychology 2005, 25:151-181.
38. Matson J.L., Fodstad J.C., Rivet T.T. The convergent and divergent validity of the Matson Evaluation of Drug Side Effects and the Dyskinesia Identification System Condensed User Scale (DISCUS). Journal of Intellectual and Developmental Disabilities 2008, 33:337-344.
39. Matson J.L., Gonzalez M.L., Terlonge C., Thorson R.T., Laud R.B. What symptoms predict the diagnosis of mania in persons with severe/profound intellectual disability in clinical practice?. Journal of Intellectual Disability Research 2007, 51:25-31.
40. Matson J.L., Lott J.D., Mayville S.B., Swender S.L., Moscow S. Depression and social skills among individuals with severe and profound mental retardation. Journal of Developmental and Physical Disabilities 2006, 18:393-400.
41. Matson J.L., LoVullo S.V. A review of behavioral treatments for self-injurious behaviors of persons with autism spectrum disorders. Behavior Modification 2008, 32:61-76.
42. Matson J.L., LoVullo S.V. Encopresis, soiling and constipation in children and adults with developmental disability. Research in Developmental Disabilities 2009, 30:799-807.
43. Matson J.L., Mayville E.A., Bamburg J.W., Eckholdt C.S. An analysis of side-effect profiles of anti-seizure medications in persons with intellectual disability using the Matson Evaluation of Drug Side Effects (MEDS). Journal of Intellectual and Developmental Disabilities 2001, 26:283-295.
44. Matson J.L., Mayville E.A., Bielecki J., Barnes W.H., Bamburg J.W., Baglio C.S. Reliability of the Matson Evaluation of Drug Side Effects Scale (MEDS). Research in Developmental Disabilities 1998, 19:501-506.
45. Matson J.L., Mayville S.B., Kuhn D.E., Sturmey P., Laud R., Cooper C. The behavioral function of feeding problems as assessed by the Questions About Behavioral Function (QABF). Research in Developmental Disabilities 2005, 26:399-408.
46. Matson J.L., Mayville E.A., Lott J.D., Bielecki J., Logan R. A comparison of social and adaptive functioning in persons with psychosis, autism, and severe or profound mental retardation. Journal of Developmental and Physical Disabilities 2003, 15:57-65.
47. Matson J.L., Neal D. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: An overview. Research in Developmental Disabilities 2009, 30:572-586.
48. Matson J.L., Rivet T.T., Fodstad J.C. Psychometric properties and participant characteristics for person with intellectual disability using the Matson Evaluation of Drug Side-effects (MEDS). Journal of Developmental and Physical Disabilities 2008, 20:243-255.
49. Matson J.L., Rivet T.T., Fodstad J.C. Matson Evaluation of Drug Side-effects (MEDS) profiles of selective serotonin reuptake inhibitors (SSRI) in adults with intellectual disability. Journal of Developmental and Physical Disabilities 2009, 21:57-68.
50. Matson J.L., Rush K.S., Hamilton M., Anderson S.J., Bamburg J.W., Baglio C.S., et al. Characteristics of depression as assessed by the Diagnostic Assessment for the Severely Handicapped-II (DASH-II). Research in Developmental Disabilities 1999, 20:305-313.
51. Matson J.L., Smiroldo B.B. Validity of the mania subscale of the Diagnostic Assessment for the Severely Handicapped-II (DASH-II). Research in Developmental Disabilities 1997, 18:221-225.
52. Matson J.L., Terlonge C., Gonzalez M.L., Rivett T. An evaluation of social and adaptive skills in adults with bipolar disorder and severe/profound intellectual disability. Research in Developmental Disabilities 2006, 27:681-687.
53. McBrien J.A. Assessment and diagnosis of depression in people with intellectual disability. Journal of Intellectual Disability Research 2003, 47:1-13.
54. McGillivray J.A., McCabe M.P. Pharmacological management of challenging behavior in individuals with intellectual disabilities. Research in Developmental Disabilities 2004, 25:523-537.
55. Paclawskyj T.R., Matson J.L., Rush K.S., Smalls Y., Vollmer T.R. Assessment of the convergent validity of the Questions About Behavioral Function scale with analogue functional analysis and the Motivation Assessment Scale. Journal of Intellectual Disability Research 2001, 45:484-494.
56. Preston J.D., O'Neal J.H., Talaga M.C. Consumer's guide to psychiatric drugs 2009, Simon & Schuster, New York.
57. Richman D.M., Wacker D.P., Asmus J.M., Casey S.D. Functional analysis and extinction of different behavior problems exhibited by the same individual. Journal of Applied Behavioral Analysis 1998, 31:475-478.
58. Rose E., Bramham J., Young S., Paliokostas E., Xenitidis K. Neurophsycological characteristics of adults with comorbid ADHD and borderline/mild intellectual disability. Research in Developmental Disabilities 2009, 30:496-502.
59. Singh A.W., Matson J.L., Mouttapa M., Pella R.D., Hill B.D., Thorson R. A critical item analysis of the QABF: Development of a short form assessment instrument. Research in Developmental Disabilities 2009, 30:782-792.
60. Singh I., Owino W.J.E. A double-blind comparison of zuclopenithixol tablets with placebo in the treatment of mentally handicapped in-patients with associated behavioural disorders. Journal of Intellectual Disability Research 1992, 36:541-549.
61. Sommi R.W., Benefield W.H., Curtis J.L., Lott R.S., Saklad J.J., Wilson J. Drug interactions with psychotropic medications. Psychotropic medication and developmental disabilities: The international consensus handbook 1998, 115-131. Ohio State University, Columbus, Ohio. S. Reiss, M.G. Aman (Eds.).
62. Strachan R., Shaw R., Burrow C., Horsler K., Allen D., Oliver C. Experimental functional analysis of aggression in children with Angelman syndrome. Research in Developmental Disabilities 2009, 30:1095-1106.
63. Symons F.J., Harper V.N., McGrath P.J., Breau L.M., Bodfish J.W. Evidence of increased non-verbal behavioral signs of pain in adults with neurodevelopmental disorders and chronic self-injury. Research in Developmental Disabilities 2009, 3:521-528.
64. Tsiouris J.A., Mann R., Patti P.J., Sturmey P. Challenging behaviours should not be considered as depressive equivalents in individuals with intellectual disability. Journal of Intellectual Disability Research 2003, 47:14-21.
65. van den Hazel T., Didden R., Korzilius H. Effects of personality disorder and other variables on professionals' evaluation of treatment features in individuals with mild intellectual disabilities and severe behavior problems. Research in Developmental Disabilities 2009, 30:547-557.